Company intelligence / Profile preview

Sylvan

Kittanning, Pennsylvania, United States

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Sylvan is a global leader in fungal technology and the world's largest producer and distributor of mushroom spawn. The company operates a specialized life sciences division, Sylvan Bio, which leverages proprietary fungal fermentation platforms to develop high-quality nutraceuticals and therapeutic ingredients. Its flagship product, Sylvan Bio Red Yeast Rice, is a standardized botanical extract used for the management of cholesterol levels. Beyond cardiovascular health, Sylvan actively conducts research into fungal-derived compounds for applications in oncology and other therapeutic areas.

Therapeutic areas: CardiovascularOncology
Modalities: Small moleculeBotanical extract
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Sylvan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sylvan.

Explore the full profile